Tuesday, December 29, 2020
On 23 December 2020, Judge Catherine Blake of the U.S. District Court for the District of Maryland granted the Pharmaceutical Research and Manufacturers of America (PhRMA) a 14-day nationwide temporary restraining order, preventing the Centers for Medicare and Medicaid Services (CMS) from implementing and enforcing its Most Favored Nation (MFN) interim final rule (MFN Rule) scheduled to take effect on 1 January 2021.
1
On 28 December 2020, in a parallel case and specifically adopting the reasoning in Judge Blake’s order, Judge Vince Chhabria of the U.S. District Court for the Northern District of California granted California Life Sciences Association (CSLA) a preliminary injunction prohibiting CMS from implementing the MFN Rule based on a failure to follow notice and comment procedures under Administrative Procedure Act (APA). Most notably, Judge Chhabria’s order vacates the MFN Rule in its entirety pending completion of the notice and com
Prospects Dim for Medicare Drug Reimbursement Cuts medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
With COVID-19, the world’s spot light has been on life science companies and San Diego is one of the hubs of the industry. Recently RSM and the San Diego Business Journal sponsored a virtual roundtable meeting to hear some of the thoughts and insights of several leaders in the industry.
Moderator:
Panelists:
Oliver Rocroi, Vice President of Communications & External Affairs, California Life Sciences Association
Edward Robles, Partner, Tax Services, San Diego Life Sciences Industry Leader, RSM
Mark Herbert, Chief Business Officer, Scientist.com
Najjam Asghar, Chief Financial Officer, Sorrento Therapeutics